Hi Grade bonds: Actavis Eyes Up To 9 tranches For Allergan M&A Play |
| March 04, 2015 | March 2015 Bond Updates |
|
After placing more than $9 billion of equity instruments last week, Actavis this morning formally announced its much-anticipated blockbuster offering of senior unsecured notes backing its $66 billion acquisition of Allergan. The deal is on track to become one of the largest on record, after the company previously signaled intentions for $22 billion of senior unsecured debt financing to accompany the recent common and mandatory convertible share deals. |
| View more at: http://www.forbes.com/sites/spleverage/2015/03/02/hi-grade-bonds-actavis-eyes-up-to-9-tranches-for-allergan-ma-play/ |
| Related News |
|